Interest is building. More buyers coming in. I agree that a re-rating could happen soon. An improvement in profits and selection of the new CEO should see CLO back around $1.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025